No Data
No Data
Today's Analyst Rating | Deutsche Bank Upgrades Boston Scientific to Buy, Morgan Stanley Upgrades Gilead Sciences to Buy
Deutsche Bank Upgrades Boston Scientific(BSX.US) to Buy Rating, Raises Target Price to $108
Boston Scientific Upgraded to Buy From Hold at Deutsche Bank
Express News | Boston Scientific : Deutsche Bank Raises Target Price to $108 From $87
Medical PET Patent Landscape Report 2025, Covering 1,408 Patents Filed From 2010 to 2024 - ResearchAndMarkets.com
Truist Financial Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $110